Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in


January 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
08 Jan 2013 - 11 Jan 2013
San Francisco, CA, USA
CHI’s High-Content Analysis
More information
SLAS2013 – 2nd Annual Conference and Exhibition
12 Jan 2013 - 16 Jan 2013
Orlando, Florida, USA
SLAS2013 – 2nd Annual Conference and Exhibition
More information
General and Advanced Receptor Theory Workshop
14 Jan 2013 - 15 Jan 2013
London, UK
General and Advanced Receptor Theory Workshop
More information
15 Jan 2013 - 21 Feb 2013
LC/MS Fundamentals and Applications
More information
Corporate Compliance & Transparency in the Pharmaceutical Sector
17 Jan 2013 - 18 Jan 2013
Prague, Czech Republic
Corporate Compliance & Transparency in the Pharmaceutical Sector
More information
22 Jan 2013 - 23 Jan 2013
Sheraton Hotel Brussels Belgium
Training ADME PK DM | Evaluation of ADMET Drug Properties in Drug Discovery and Development
More information
11th Cytokines and Inflammation Conference
31 Jan 2013 - 01 Feb 2013
San Diego, CA, USA
11th Cytokines and Inflammation Conference
More information
31 Jan 2013 - 01 Feb 2013
TATAA Biocenter, Odinsgatan 28, Gothenburg
2 days Experimental design and data analysis
More information


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos